Narrative review / 2011
A review of over 700 human studies notes strong support for probiotics in preventing or treating gastrointestinal disorders and metabolic syndrome.
This review summarizes webinar presentations by the AGA, ISAPP, and ILSI North America on the gut microbiota's influence on health and disease. It notes that over 700 randomized, controlled, human studies have demonstrated strong support for using probiotics to clinically prevent or treat gastrointestinal tract disorders and metabolic syndrome. Practical guidelines and clinical intervention strategies for probiotics and prebiotics are discussed.
- Study type
- Narrative review
- Who was studied
- Human clinical trials of probiotics (over 700 studies referenced)
- What was measured
- Gastrointestinal tract disorders and metabolic syndrome
THE PAPER
Human gut microbiota and its relationship to health and disease.
Wallace TC, Guarner F, Madsen K, Cabana MD, Gibson G, Hentges E, Sanders ME. Nutr Rev, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.